THE FOOD AND DRUG ADMINISTRATION investigation into quality-control problems at Johnson & Johnson's McNeil Consumer Healthcare division has shined a critical light on the OTC industry at a time when it can least afford such scrutiny. “Although the public risk from these quality problems is low, these problems should never have occurred,” stated Joshua Sharfstein, FDA deputy commissioner, in remarks prepared for a recent congressional hearing, noting that “the failures that caused them ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.